Home / Medical devices / Nile Pax
Nile Pax
 |
Max. value paid with public resources: Processing |
 |
Data for med. device |
| 07IIIC3417934150 |
| 21/06/2013 15:03 |
| 21/06/2013 16:53 |
| 20/06/2013 14:49 |
 | Identification of the manufacturer |
| Minvasys SAS |
| Minvasys |
| Other |
| Commercial Register |
| 448-568-212 00030 |
| FR |
| Gennevilliers |
| 92230 |
| 7 rue du Fosse Blanc - Batiment C1 |
| Luc Demangeon |
| +33 (0) 1 47 90 70 42 |
| +33 (0) 1 47 91 05 85 |
| ldemangeon@minvasys.com |
 | Identification of the person placing the product on the market |
| RSR Ltd. |
| EIK |
| 121706547 |
| BG |
| SOF |
| Sofia |
| 1606 |
| 3 Victor Grigorovich |
| Emilia Andreeva |
| 02 951 59 76 |
| 02 951 59 32 |
| e.andreeva@rsr.bg |
 | Identification of the wholesaler |
| RSR Ltd. |
| EIK |
| 121706547 |
| BG |
| SOF |
| Sofia |
| 1606 |
| 3 Victor Grigorovich |
| Emilia Andreeva |
| 02 951 59 76 |
| 02 951 59 32 |
| e.andreeva@rsr.bg |
| ІV-Р-Т/МИ-021/29.08.2007 |
| 29/08/2007 |
 | General medical information about the device |
| 07 - Non-active implantable devices |
| Class ІІІ |
| Cardiovascular system |
| GMDN |
| 34179 |
| Nile Pax |
 | Description of the medical device |
| 1 |
| Sterility, Hospital prescription |
|
Paclitaxel |
 | Intended action by the manufacturer |
| The Nile PAX® intracoronary stent system is exclusively and specifically intended for use in the treatment of patients with clinical symptoms of myocardial ischemia related to the pathological condition of de novo coronary arteries lesions located on bifurcation sites, excluding left main trunk. |
| Single use |
 | General trade information |
| Processing |
| IAL5789/05.02.2013 |
| 05/02/2013 |
| 17768 |
| 10/12/2014 |
